Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System
Adverse Drug Reaction (ADR)This project addresses the problem of adverse drug reactions in the three most frequently prescribed therapeutic classes of drugs in children: antibiotics, analgesics, and mental health medications.
We will conduct pilot testing of a pharmacogenomic testing panel and study how the tests and generated test results are utilized and understood by physicians, pharmacists, patients and their families.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
0 and up
Participation Criteria
Inclusion Criteria:
* Participants will be enrolled if they can benefit from pharmacogenomic testing. This means their physician is considering the use of a drug that is part of the panels (analgesics, antibiotics, and mental health medication) or they are already using one.
Exclusion Criteria:
* Patients who do not speak or understand English.
Study Location
Children's and Women's Health Centre of British Columbia
Children's and Women's Health Centre of British ColumbiaVancouver, British Columbia
Canada
Contact Study Team
Children's Hospital of Eastern Ontario
Children's Hospital of Eastern OntarioOttawa, Ontario
Canada
Contact Study Team
- Study Sponsored By
- University of British Columbia
- Participants Required
- More Information
- Study ID:
NCT04249375